Molecular Partners Ag -adr (MOLN) Technical Analysis
$4.05▲2.16%
Market is closed - opens 7 PM, 12 May 2025
Insights
- Molecular Partners Ag -adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Molecular Partners Ag -adr stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Molecular Partners Ag -adr stock is Range bound.
- Based on analysis of the Pivot Points, the current market trend for Molecular Partners Ag -adr stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 50.9 | Neutral |
Stochastic | 61.61, 64.41 | Neutral |
Ultimate Oscillator | 53.91 | Neutral |
Stochastic Relative Strength Index | 65.85, 76.98 | Neutral |
Moving Average Convergence Divergence | 0.0, -0.04 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.0 | Buy |
20 | 3.95 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.02 | Buy |
20 | 3.99 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.03 | Neutral |
20 | 4.09 | Neutral |
50 | 4.12 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.07 | Buy |
20 | 3.98 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.09 | Sell |
20 | 4.09 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 4.39 |
Resistance L2 | 4.31 |
Resistance L1 | 4.13 |
Pivot Point | 4.05 |
Support L1 | 3.88 |
Support L2 | 3.79 |
Support L3 | 3.62 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.